Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates

Kronos Bio, Inc. (KRON) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of$ 0.26. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11.54%. A quarter ago, it was expected that this company would post a loss of$ 0.32 per share when it actually produced a loss of $0.27, delivering a surprise of 15.63%.Over the last four quarters, the company has surpass ...